These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 9062331)
41. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Hampel H; Stephens JA; Pukkala E; Sankila R; Aaltonen LA; Mecklin JP; de la Chapelle A Gastroenterology; 2005 Aug; 129(2):415-21. PubMed ID: 16083698 [TBL] [Abstract][Full Text] [Related]
42. Genetic basis of familial endometrial cancer: is there more to learn? Boyd J J Clin Oncol; 2005 Jul; 23(21):4570-3. PubMed ID: 15837976 [No Abstract] [Full Text] [Related]
43. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584 [TBL] [Abstract][Full Text] [Related]
44. [Can an online risk assessment tool for identification of hereditary colorectal cancer reach the at-risk population and influence screening compliance?]. Schürmanns K; Gelos M; Felder G; Schneider R; Möslein G Dtsch Med Wochenschr; 2014 May; 139(18):935-40. PubMed ID: 24760714 [TBL] [Abstract][Full Text] [Related]
45. Amsterdam criteria II and endometrial cancer index cases for an accurate selection of HNPCC families. Fornasarig M; Viel A; Bidoli E; Campagnutta E; Minisini AM; Cannizzaro R; Della Puppa L; Boiocchi M Tumori; 2002; 88(1):18-20. PubMed ID: 12004844 [TBL] [Abstract][Full Text] [Related]
46. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893 [TBL] [Abstract][Full Text] [Related]
48. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis. Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R Oncology; 2015; 88(4):226-33. PubMed ID: 25503195 [TBL] [Abstract][Full Text] [Related]
49. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Kong S; Amos CI; Luthra R; Lynch PM; Levin B; Frazier ML Cancer Res; 2000 Jan; 60(2):249-52. PubMed ID: 10667569 [TBL] [Abstract][Full Text] [Related]
50. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. Matloff ET; Shappell H; Brierley K; Bernhardt BA; McKinnon W; Peshkin BN J Clin Oncol; 2000 Jun; 18(12):2484-92. PubMed ID: 10856109 [TBL] [Abstract][Full Text] [Related]
51. Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer. Stormorken AT; Clark N; Grindedal E; Maehle L; Møller P Scand J Gastroenterol; 2007 May; 42(5):611-7. PubMed ID: 17454882 [TBL] [Abstract][Full Text] [Related]
52. Genetic alteration in hereditary colorectal cancer. Dionigi G; Bianchi V; Rovera F; Boni L; Annoni M; Castano P; Villa F; Dionigi R Surg Oncol; 2007 Dec; 16 Suppl 1():S11-5. PubMed ID: 18023570 [TBL] [Abstract][Full Text] [Related]
53. Criteria and prediction models for mismatch repair gene mutations: a review. Win AK; Macinnis RJ; Dowty JG; Jenkins MA J Med Genet; 2013 Dec; 50(12):785-93. PubMed ID: 23956446 [TBL] [Abstract][Full Text] [Related]
54. Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study. Kalamo MH; Mäenpää JU; Seppälä TT; Mecklin JP; Huhtala H; Sorvettula K; Pylvänäinen K; Staff S Fam Cancer; 2020 Apr; 19(2):177-182. PubMed ID: 31997047 [TBL] [Abstract][Full Text] [Related]
55. Hereditary nonpolyposis colorectal cancer: preventive management. Annie Yu HJ; Lin KM; Ota DM; Lynch HT Cancer Treat Rev; 2003 Dec; 29(6):461-70. PubMed ID: 14585257 [TBL] [Abstract][Full Text] [Related]
56. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Wagner A; van Kessel I; Kriege MG; Tops CM; Wijnen JT; Vasen HF; van der Meer CA; van Oostrom II; Meijers-Heijboer H Fam Cancer; 2005; 4(4):295-300. PubMed ID: 16341806 [TBL] [Abstract][Full Text] [Related]
57. Gynecological tumors revealing hereditary nonpolyposis colorectal cancer: analysis of a large Lebanese pedigree. Akoum R; Ghaoui A; Brihi E; Ghabash M; Abou Atme J Int J Gynecol Cancer; 2006; 16(4):1516-21. PubMed ID: 16884359 [TBL] [Abstract][Full Text] [Related]
58. Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome. Schmeler KM; Daniels MS; Soliman PT; Broaddus RR; Deavers MT; Vu TM; Chang GJ; Lu KH Obstet Gynecol; 2010 Feb; 115(2 Pt 2):432-434. PubMed ID: 20093870 [TBL] [Abstract][Full Text] [Related]
59. Endometrial cancer patients and compliance with genetic counseling: room for improvement. Backes FJ; Mitchell E; Hampel H; Cohn DE Gynecol Oncol; 2011 Dec; 123(3):532-6. PubMed ID: 21968342 [TBL] [Abstract][Full Text] [Related]
60. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Mellon I; Rajpal DK; Koi M; Boland CR; Champe GN Science; 1996 Apr; 272(5261):557-60. PubMed ID: 8614807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]